Association of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology

References

• Pharmacovigilance: Overview | European Medicines Agency. [cited 2022 Apr 30]. Avialable from: https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview
   Google Scholar
• Practical aspects of signal detection in pharmacovigilance. [cited 2022 Jul 2]. Available from: https://cioms.ch/wp-content/uploads/2018/03/WG8-Signal-Detection.pdf
   Google Scholar
• Centre for Drug Evaluation and Research. FDA Adverse Event Reporting System (FAERS) Public Dashboard. U.S. Food and Drug Administration. 2021 Oct 23 [cited 2022 Jul 2]. Available from: https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard
   Google Scholar
• Böhm R, von Hehn L, Herdegen T, et al. OpenVigil FDA–inspection of US American adverse drug events pharmacovigilance data and novel clinical applications. PLoS One. 2016 Jun 21;11(6):e0157753. doi: 10.1371/journal.pone.0157753
   PubMed Web of Science ®Google Scholar
• Sandberg L, Taavola H, Aoki Y, et al. Risk factor considerations in statistical signal detection: using subgroup disproportionality to uncover risk groups for adverse drug reactions in VigiBase. Drug Saf. 2020 Oct;43(10):999–1009. doi: 10.1007/s40264-020-00957-w
   PubMed Web of Science ®Google Scholar
• Sharma A, Kumar A. Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: a disproportionality analysis. Acta Neurol Scand. 2022;146(5):623–627. doi: 10.1111/ane.13690
   PubMed Web of Science ®Google Scholar
• Javed F, Kumar A. Identification of signal of clindamycin associated renal failure acute: a disproportionality analysis. Curr Drug Saf. 2023;19(1):123–128. doi: 10.2174/1574886318666230228142856
   Web of Science ®Google Scholar
• Sharma A, Roy S, Sharma R, et al. Association of antiviral drugs and their possible mechanisms with DRESS syndrome using data mining algorithms. J Med Virol. 2023;95(3):e28671. doi: 10.1002/jmv.28671
   PubMed Web of Science ®Google Scholar
• Jain D, Sharma G, Kumar A. Adverse effects of proton pump inhibitors (PPIs) on the renal system using data mining algorithms (DMAs). Expert Opin Drug Saf. 2023;22:1–12. doi: 10.1080/14740338.2023.2189698
   PubMed Web of Science ®Google Scholar
• Dinnes J, Cave C, Huang S, et al. A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. Br J Cancer. 2002 Feb;86(4):501–505. doi: 10.1038/sj.bjc.6600135
   PubMed Web of Science ®Google Scholar
• Yasaswi PS, Shetty K, Yadav KS. Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. JControlled Release. 2021 Aug 10;336:549–571. doi: 10.1016/j.jconrel.2021.07.003
   PubMed Web of Science ®Google Scholar
• Bae SH, Park MJ, Lee MM, et al. Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in Korea. J Korean Med Sci. 2014 Jul 1;29(7):980–984. doi: 10.3346/jkms.2014.29.7.980
   PubMed Web of Science ®Google Scholar
• Onwubiko I, Taneja K, Gupta N, et al. Progressive multifocal leukoencephalopathy presenting as transverse myelitis.
   Google Scholar
• Williamson EM, Berger JR. Diagnosis and treatment of progressive multifocal leukoencephalopathy associated with multiple sclerosis therapies. Neurotherapeutics. 2017 Oct;14(4):961–973. doi: 10.1007/s13311-017-0570-7
   PubMed Web of Science ®Google Scholar
• Yukitake M. Drug‐induced progressive multifocal leukoencephalopathy in multiple sclerosis: A comprehensive review. Clin Exp Neuroim. 2018 Mar;9(S1):37–47. doi: 10.1111/cen3.12440
   Google Scholar
• Roger JY, Krantz MS, Phillips EJ, et al. Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA adverse event Reporting System (FAERS). J Allergy Clin Immunol Pract. 2021 Feb 1;9(2):819–829. doi: 10.1016/j.jaip.2020.09.021
   PubMed Web of Science ®Google Scholar
• Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001 Oct;10(6):483–486. doi: 10.1002/pds.677
   PubMed Web of Science ®Google Scholar
• Xin WA, Zi-Yi WA, Zheng JH, et al. TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med. 2021 Jan 1;19(1):1–1. doi: 10.1016/S1875-5364(21)60001-8
   PubMed Web of Science ®Google Scholar
• Ahadi EM, Azizian H, Vavsari VF, et al. Synthesis and decarboxylation of functionalized 2-pyridone-3-carboxylic acids and evaluation of their antimicrobial activity and molecular docking. Iran J Pharm Res. 2021;20(3):456.
   PubMed Web of Science ®Google Scholar
• Wu J, Langford LA, Schellingerhout D, et al. Progressive multifocal leukoencephalopathy in a patient with glioblastoma. J Neurooncol. 2011 Jul;103(3):791–796. doi: 10.1007/s11060-010-0453-9
   PubMed Web of Science ®Google Scholar
• Picca A, Desjardins C, Bihan K, et al. Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma. Neuro Oncol. 2022 Mar;24(3):497–498. doi: 10.1093/neuonc/noab306
   PubMed Web of Science ®Google Scholar
• Joly M, Conte C, Cazanave C, et al. Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions. Brain. 2023 Jan;146(1):349–358. doi: 10.1093/brain/awac237
   PubMed Web of Science ®Google Scholar
• Le Rhun E, Oppong FB, Vanlancker M, et al. Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma. Neuro Oncol. 2022 Sep 1;24(9):1533–1545. doi: 10.1093/neuonc/noac070
   PubMed Web of Science ®Google Scholar
• Su YB, Sohn S, Krown SE, et al. Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol. 2004 Feb 15;22(4):610–616. doi: 10.1200/JCO.2004.07.060
   PubMed Web of Science ®Google Scholar
• Singh R, Kumar A, Lather V, et al. Identification of novel signal of Raynaud’s phenomenon with calcitonin gene-related peptide (CGRP) antagonists using data mining algorithms and network pharmacological approaches. Expert Opin Drug Saf. 2023;1–8.
   PubMed Web of Science ®Google Scholar
• Wilczek MP, Armstrong FJ, Mayberry CL, et al. PI3K/AKT/mTOR signaling pathway is required for JCPyV infection in primary astrocytes. Cells. 2021 Nov 18;10(11):3218. doi: 10.3390/cells10113218
   PubMed Web of Science ®Google Scholar
• Gupta M, Sharma R, Kumar A. Docking techniques in pharmacology: how much promising? Comput Biol Chem. 2018;76:210–217. doi: 10.1016/j.compbiolchem.2018.06.005
   PubMed Web of Science ®Google Scholar
• Gupta M, Sharma R, Kumar A. Docking techniques in toxicology: an overview. Curr Bioinf. 2020;15(6):600–610. doi: 10.2174/1574893614666191003125540
   Web of Science ®Google Scholar